Suppr超能文献

血红蛋白溶液:一种潜在的氧输送性血浆容量扩充剂。

Hemoglobin solution: a potential oxygen transporting plasma volume expander.

作者信息

Kaplan H R, Murthy V S

出版信息

Fed Proc. 1975 May;34(6):1461-5.

PMID:1126443
Abstract

The potential of a 6% stroma-free human hemoglobin solution (WXb8326) as a plasma volume expander with oxygen transport capabilities was evaluated in barbiturate-anesthetized spontaneously breathing dogs. WXb8326 compared favorably with dextran-70 and 5% albumin solution as a plasma volume expander. Serial phlebotomies to a blood pressure of 35 mm Hg and immediate replacement with the above colloid expanders showed that only WXb8326-exchanged dogs survived acute reductions in hematocrit to critical levels of smaller than or equal to 5%. After several exchanges with WXb8326 to levels as low as 1%, it was possible to demonstrate acute survival. With less drastic reductions in the hematocrit (between 5 and 10%) all dogs survived acutely regardless of the type of plasma volume expander used; however, subacute survival rates varied. Oxygen transport characteristics during isovolumic hemodilution (phlebotomy and simultaneous replacement with WXb8326) were studied in a separate series of spontaneously breathing dogs in which hematocrit was reduced to approximately 50% of control. Oxygen content of erythrocytic hemoglobin (EHb) and extraerythrocytic hemoglobin (EEHb) resulting from infusions of WXb8326 was studied in arterial and venous blood at different levels of hemodilution. WXb8326 did not interfere with the arterial oxygen saturation of EHb in the pulmonary vascular bed and EEHb was oxygenated as efficiently as EHb. Oxygen delivery to tissues differed between EHb and EEHb. Erythrocytic hemoglobin met oxygen demands under basal conditions while EEHb contributed oxygen to tissues during conditions of high oxygen extraction. It is concluded that WXb8326 is an attractive condidate as a plasma volume expander with the capacity to transport oxygen to tissues.

摘要

在巴比妥麻醉、自主呼吸的犬中评估了6%无基质人血红蛋白溶液(WXb8326)作为具有氧运输能力的血浆容量扩充剂的潜力。作为血浆容量扩充剂,WXb8326与右旋糖酐70和5%白蛋白溶液相比具有优势。连续放血至血压为35毫米汞柱并立即用上述胶体扩充剂替代,结果显示只有用WXb8326置换的犬在血细胞比容急性降至小于或等于5%的临界水平时存活。用WXb8326进行几次置换至低至1%的水平后,有可能证明急性存活。血细胞比容降低幅度较小(5%至10%之间)时,无论使用何种血浆容量扩充剂,所有犬均能急性存活;然而,亚急性存活率有所不同。在另一组自主呼吸的犬中研究了等容血液稀释(放血并同时用WXb8326置换)期间的氧运输特性,这些犬的血细胞比容降至约为对照值的50%。在不同血液稀释水平下,研究了动脉血和静脉血中因输注WXb8326而产生的红细胞血红蛋白(EHb)和红细胞外血红蛋白(EEHb)的氧含量。WXb8326不干扰肺血管床中EHb的动脉血氧饱和度,并且EEHb与EHb一样有效地被氧合。EHb和EEHb向组织输送氧气的情况有所不同。红细胞血红蛋白在基础条件下满足氧需求,而EEHb在高氧摄取条件下向组织供氧。结论是,WXb8326作为一种能够向组织输送氧气的血浆容量扩充剂是一个有吸引力的候选者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验